499 related articles for article (PubMed ID: 2598478)
1. Variable effects of RU 486 on endometrial maintenance in the luteal phase extended by exogenous hCG.
Croxatto HB; Salvatierra AM; Croxatto HD; Spitz IM
Clin Endocrinol (Oxf); 1989 Jul; 31(1):15-23. PubMed ID: 2598478
[TBL] [Abstract][Full Text] [Related]
2. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.
Gemzell-Danielsson K; Swahn ML; Svalander P; Bygdeman M
Hum Reprod; 1993 Jun; 8(6):870-3. PubMed ID: 8345076
[TBL] [Abstract][Full Text] [Related]
3. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
[TBL] [Abstract][Full Text] [Related]
4. The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium.
Swahn ML; Bygdeman M; Cekan S; Xing S; Masironi B; Johannisson E
Hum Reprod; 1990 May; 5(4):402-8. PubMed ID: 2113927
[TBL] [Abstract][Full Text] [Related]
5. Effect of tamoxifen alone and in combination with RU 486 on the endometrium in the mid-luteal phase.
Swahn ML; Bygdeman M; Seppälä M; Johannisson E; Cekan S
Hum Reprod; 1993 Feb; 8(2):193-200. PubMed ID: 8473418
[TBL] [Abstract][Full Text] [Related]
6. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[TBL] [Abstract][Full Text] [Related]
7. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
Schaison G; George M; Lestrat N; Reinberg A; Baulieu EE
J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
[TBL] [Abstract][Full Text] [Related]
8. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
Roseff SJ; Kettel LM; Rivier J; Burger HG; Baulieu E; Yen SS
Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914
[TBL] [Abstract][Full Text] [Related]
9. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
Greene KE; Kettel LM; Yen SS
Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899
[TBL] [Abstract][Full Text] [Related]
10. Luteal contraception.
Yen S; Garzo G; Liu J
Contraception; 1987; 36 Suppl():13-25. PubMed ID: 2824125
[TBL] [Abstract][Full Text] [Related]
11. Mode of action of RU 486.
Bygdeman M; Swahn ML; Gemzell-Danielsson K; Svalander P
Ann Med; 1993 Feb; 25(1):61-4. PubMed ID: 8435191
[TBL] [Abstract][Full Text] [Related]
12. Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy.
Batista MC; Cartledge TP; Zellmer AW; Merino MJ; Axiotis C; Loriaux DL; Nieman LK
Am J Obstet Gynecol; 1992 Jul; 167(1):60-5. PubMed ID: 1442957
[TBL] [Abstract][Full Text] [Related]
13. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
Croxatto HB; Salvatierra AM; Romero C; Spitz IM
J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
[TBL] [Abstract][Full Text] [Related]
14. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
[TBL] [Abstract][Full Text] [Related]
15. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
Fraser HM; Nestor JJ; Vickery BH
Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
[TBL] [Abstract][Full Text] [Related]
16. Effects of a sequential regimen of mifepristone-medroxyprogesterone acetate on ovarian function, endometrial development and hormonal parameters.
Croxatto HB; Massai MR; Salvatierra AM; Fuentealba B; Croxatto HD; Lähteenmäki P
Contraception; 1996 Aug; 54(2):79-86. PubMed ID: 8842583
[TBL] [Abstract][Full Text] [Related]
17. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
[TBL] [Abstract][Full Text] [Related]
18. The use of anti-progesterones as a medical IUD.
Nieman LK; Loriaux DL
Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):609-16. PubMed ID: 3233821
[TBL] [Abstract][Full Text] [Related]
19. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
Luukkainen T; Heikinheimo O; Haukkamaa M; Lähteenmäki P
Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
